3103 studies found for:    Open Studies | "Metabolic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Chung-ju Metabolic Disease Cohort (CMC) Study
Condition: Metabolic Diseases
Intervention:
2 Recruiting Hepatocyte Transplantation for Liver Based Metabolic Disorders
Condition: Metabolic Diseases
Interventions: Drug: human hepatocyte transplantation;   Radiation: Preparative Radiation Therapy
3 Recruiting Survey on Cardiovascular Events in Patients With Metabolic Disease on Chronic Carnitine Supplementation
Condition: Metabolic Disorders
Intervention:
4 Recruiting MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
5 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
6 Recruiting Impact of Peer Support on Diabetes in China
Conditions: Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases;   Diabetes
Interventions: Behavioral: peer support;   Other: usual education lectures
7 Recruiting Comparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference Technique
Conditions: Diabetes Mellitus;   Insulin Resistance;   Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases
Interventions: Drug: 6-DIG;   Procedure: clamp
8 Unknown  Pharmacokinetics Study of Gamma-aminobutyric Acid
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Metabolic Diseases;   Endocrine System Diseases;   Autoimmune Diseases;   Immune System Diseases
Intervention:
9 Unknown  Aldosterone and the Metabolic Syndrome
Conditions: Metabolic Diseases;   Diabetes Mellitus;   Endocrine System Diseases;   Glucose Metabolism Disorders
Interventions: Drug: Renin-Angiotensin-Aldosterone System (RAAS) Activation;   Drug: Administration of Aliskiren, Spironolactone, or Placebo;   Drug: Increased Dose, Combination, or Placebo
10 Not yet recruiting A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders
Condition: Metabolic Disorders
Intervention: Biological: ProHema-CB Transplant
11 Recruiting EPI-743 for Metabolism or Mitochondrial Disorders
Conditions: Undiagnosed Diseases;   Metabolic Disease;   Neurology;   Myoptahy;   Oxidation/Reduction;   Mitochondrial Disorders
Intervention: Drug: EPI-743
12 Recruiting Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
Conditions: Liver Diseases, Alcoholic;   Metabolic Diseases
Intervention: Other: Intervention according to the standard of care.
13 Unknown  The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease
Conditions: Metabolic Diseases;   Chronic Kidney Disease
Intervention:
14 Recruiting Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome
Conditions: Obesity;   Metabolic Disease
Interventions: Drug: Colchicine 0.6 mg given;   Drug: Placebo capsules given
15 Unknown  Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients
Condition: Nutritional and Metabolic Disease
Interventions: Dietary Supplement: vitamin D3 supplement;   Dietary Supplement: calcium supplement;   Dietary Supplement: vitamin D3 and calcium supplement;   Dietary Supplement: placebo
16 Recruiting Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
Conditions: HIV;   Lipodystrophy
Intervention:
17 Recruiting UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Conditions: Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
Intervention: Biological: DUOC-01
18 Unknown  Effect of Taurine on Glycemic Control in Type I and Type II Diabetic Patients
Conditions: it is a Group of Metabolic Diseases in;   Which a Person Has High Blood Sugar, Either;   Because the Body Does Not Produce Enough Insulin,;   or Because Cells do Not Respond to the Insulin That;   is Produced.
Intervention: Drug: Taurine
19 Recruiting Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance
Condition: Gastric Cancer With Metabolic Syndrome or Metabolic Disease
Interventions: Procedure: subtotal gastrectomy with gastroduodenostomy;   Procedure: subtotal gastrectomy with Roux-en-Y gastrojejunostomy,;   Procedure: total gastrectomy with Rou-en-Y esophagojejunostomy
20 Recruiting Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Conditions: Metabolic Disease;   Seizures
Interventions: Drug: SGS-742;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years